Examples of key roles played by ECM proteoforms abound in the context of cancer: proteoforms arising from alternative splicing of fibronectin or tenascin-C are specifically detected in tumors but not healthy tissues and have been shown to promote tumor progression (143, 144, 145). This evidence concerns the gene FN1 and cancer.